These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8221661)

  • 21. Mutations in the p53 gene in primary human breast cancers.
    Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
    Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J; Thompson AM; Cranston G; Evans HJ
    Oncogene; 1990 Oct; 5(10):1573-9. PubMed ID: 2250913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood.
    Boman F; Peters J; Ragge N; Triche T
    Diagn Mol Pathol; 1993 Mar; 2(1):14-22. PubMed ID: 8287221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
    Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC
    Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B; Dressler A; Reifinger M; Feil C
    Am J Vet Res; 1998 Jan; 59(1):69-78. PubMed ID: 9442248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of codon 72 polymorphism of p53 gene from blood and loss of heterozygosity in brain tumors using polymerase chain reaction].
    Iijima J; Sawa H; Shiina Y; Hoshino T
    No To Shinkei; 1993 Jan; 45(1):43-7. PubMed ID: 8476653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
    Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
    Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus.
    Lee JY; Dong SM; Shin MS; Kim SY; Lee SH; Kang SJ; Lee JD; Kim CS; Kim SH; Yoo NJ
    Biochem Biophys Res Commun; 1997 Aug; 237(3):667-72. PubMed ID: 9299424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 gene mutation spectrum in human unknown primary tumors.
    Bar-Eli M; Abbruzzese JL; Lee-Jackson D; Frost P
    Anticancer Res; 1993; 13(5A):1619-23. PubMed ID: 8239543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands.
    Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM
    Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No CDKN2 mutations in neuroblastomas.
    Beltinger CP; White PS; Sulman EP; Maris JM; Brodeur GM
    Cancer Res; 1995 May; 55(10):2053-5. PubMed ID: 7743501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutations in nonastrocytic human brain tumors.
    Ohgaki H; Eibl RH; Wiestler OD; Yasargil MG; Newcomb EW; Kleihues P
    Cancer Res; 1991 Nov; 51(22):6202-5. PubMed ID: 1933879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S; Börresen AL; Eyfjörd JE
    Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.